Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon.: RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants

被引:57
作者
Vilaró, MT
Doménech, T
Palacios, JM
Mengod, G
机构
[1] CSIC, IDIBAPS, Inst Invest Biomed Barcelona, Dept Neurochem, Barcelona 08036, Spain
[2] Almirall Prodesfarma SA, Barcelona 08036, Spain
关键词
5-HT4; receptors; C-terminal splice variants; H-3]GR 113808; receptor constitutive activity; human brain distribution;
D O I
10.1016/S0028-3908(01)00154-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have cloned a novel C-terminal splice variant of serotonin 5-HT4 receptors from human hippocampus. The deduced protein extends only one aminoacid past the splicing point. We propose to call the novel variant h5-HT4(n) since it contains none of the C-terminal exons alternatively spliced in other variants. The pharmacological profile of h5-HT4(n) stably expressed in HeLa cells is in agreement with other reported variants. Stably transfected cells showed increased basal levels of intracellular cAMP in absence of agonist, indicating constitutive activity of the expressed receptors. 5-HT induced robust increases of intracellular cAMP. The 5-HT4 receptor antagonist GR 113808 blocked the effects of 5-HT and brought intracellular cAMP below basal constitutive levels. indicating inverse agonism of this compound in this system. The RT-PCR distribution of all known human C-terminal splice variants in human brain regions and periphery showed complex patterns of variant expression, with the novel variant h5-HT4(n) being widely and abundantly expressed. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:60 / 73
页数:14
相关论文
共 39 条
  • [1] Modulation of forskolin-mediated adenylyl cyclase activation by constitutively active GS-coupled receptors
    Alewijnse, AE
    Smit, MJ
    Pena, MSR
    Verzijl, D
    Timmerman, H
    Leurs, R
    [J]. FEBS LETTERS, 1997, 419 (2-3): : 171 - 174
  • [2] 5-HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle
    Bach, T
    Syversveen, T
    Kvingedal, AM
    Krobert, KA
    Brattelid, T
    Kaumann, AJ
    Levy, FO
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (02) : 146 - 160
  • [3] Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant
    Bender, E
    Pindon, A
    van Oers, I
    Zhang, YB
    Gommeren, W
    Verhasselt, P
    Jurzak, M
    Leysen, J
    Luyten, W
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 74 (02) : 478 - 489
  • [4] The 5-HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5-HT4(c) receptor
    Blondel, O
    Gastineau, M
    Langlois, M
    Fischmeister, R
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) : 595 - 597
  • [5] Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium
    Blondel, O
    Vandecasteele, G
    Gastineau, M
    Leclerc, S
    Dahmoune, Y
    Langlois, M
    Fischmeister, R
    [J]. FEBS LETTERS, 1997, 412 (03) : 465 - 474
  • [6] Blondel O, 1998, J NEUROCHEM, V70, P2252
  • [7] Bonaventure P, 2000, SYNAPSE, V36, P35, DOI 10.1002/(SICI)1098-2396(200004)36:1<35::AID-SYN4>3.0.CO
  • [8] 2-Y
  • [9] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [10] Pharmacological properties of 5-hydroxytryptamine4 receptor antagonists on constitutively active wild-type and mutated receptors
    Claeysen, S
    Sebben, M
    Bécamel, C
    Eglen, RM
    Clark, RD
    Bockaert, J
    Dumuis, A
    [J]. MOLECULAR PHARMACOLOGY, 2000, 58 (01) : 136 - 144